Adjuvant effect of CpG-oligodeoxynucleotide in anti-fungal chemotherapy against fatal infection with Cryptococcus neoformans in mice

Takeshi Kinjo, Kazuya Miyagi, Kiwamu Nakamura, Futoshi Higa, Xiao Gang, Akiko Miyazato, Mitsuo Kaku, Jiro Fujita, Kazuyoshi Kawakami

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cryptococcal meningoencephalitis is a life-threatening infectious disease in immunocompromised patients. Unmethylated CpG-oligodeoxynucleotides (CpG-ODN) protects hosts in a mouse model. In the present study, we tested the adjuvant effect of CpG-ODN in anti-fungal chemotherapy. Administration of either fluconazole (FLCZ) or CpG-ODN was effective in extending survival, accelerating clearance of fungi and preventing disseminated infection. Combination of both agents provided more beneficial effect than either agent alone. Cytokine balance in the infected lungs was biased to Th1-type response by CpG-ODN, while FLCZ did not further promote. These results suggest that CpG-ODN is a promising adjuvant in chemotherapy against this infection.

Original languageEnglish
Pages (from-to)741-746
Number of pages6
JournalMICROBIOLOGY and IMMUNOLOGY
Volume51
Issue number8
DOIs
Publication statusPublished - 2007

Keywords

  • CpG-DNA
  • Cryptococcus neoformans
  • Fluconazole
  • Th1 cytokines

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Virology

Fingerprint Dive into the research topics of 'Adjuvant effect of CpG-oligodeoxynucleotide in anti-fungal chemotherapy against fatal infection with Cryptococcus neoformans in mice'. Together they form a unique fingerprint.

  • Cite this